Guadecitabine and Nivolumab in Treating Refractory Metastatic Colorectal Cancer

NCT03576963 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped No funding

Conditions

Colorectal Adenocarcinoma
CpG Island Methylator Phenotype
Metastatic Microsatellite Stable Colorectal Carcinoma
Refractory Colorectal Carcinoma
Stage IV Colorectal Cancer AJCC v8
Stage IVA Colorectal Cancer AJCC v8
Stage IVB Colorectal Cancer AJCC v8
Stage IVC Colorectal Cancer AJCC v8

Interventions

DRUG: Guadecitabine
BIOLOGICAL: Nivolumab

Sponsor

University of Southern California

Collaborators

[object Object]
[object Object]
[object Object]